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incident osteophytes at 30 months, respectively, using Poisson regression
with GEE in knee-based analyses. We performed additional analyses on a
subregion-basis. Given the systemic effects of vitamin K, we also performed
person-based analyses examining the relation of vitamin K deﬁciency with
risk for having incident OA in 1 or 2 knees. All analyses were adjusted for
age, sex, BMI, BMD and 25(OH)-vitamin D.
Results: Among 1180 participants (62% women, mean age 62±7.9 years,
mean BMI 30.1±5.1 kg/m2, median vitamin K 1.2 nM), 21% developed inci-
dent knee OA over 30 month follow-up and 9.2% were vitamin K deﬁcient
at baseline. In the knee-based analyses, compared with those who were not
vitamin K deﬁcient, those who were deﬁcient had 1.43 times higher risk of
incident radiographic OA (95% CI 0.98-2.09), and 2.82 times higher risk of
incident cartilage abnormality (95% CI 1.26-6.30). Vitamin K deﬁciency was
not statistically signiﬁcantly associated with incident osteophytes in the
knee-based analyses (RR 1.77, 95% CI 0.41-7.55), although this sample was
small as most knees had some osteophytes at baseline and were therefore
excluded. The risk of incident osteophytes on a subregion basis was similar
to the knee-based analyses (RR 1.61, 95% CI 0.71-3.66). In the person-based
analyses, those who were vitamin K deﬁcient were more likely to develop
incident OA in 2 knees versus 0 knees (RR 2.07, 95% CI 1.28-3.36), 2 knees
versus 1 knee (RR 2.76, 95% CI 0.99-7.69) and 1 knee versus 0 knees (RR
1.23, 95% CI 1.01-1.50).
Conclusions: In this ﬁrst longitudinal study of vitamin K in OA, we found
that vitamin K deﬁciency was associated with an increased risk of incident
knee OA, extending prior cross-sectional ﬁndings, as well as with incident
cartilage abnormalities. We could not detect an association with incident
osteophytes but most knees had osteophytes at baseline, limiting sample
size for this analysis. Further study of vitamin K is warranted given its
potential to be a simple and effective preventive agent.
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Purpose: The Osteoarthritis Initiative provides an excellent source of public
use data for the study of prognostic factors that may inﬂuence pain and
functional status of patients with knee osteoarthritis. An extensive litera-
ture has examined various prognostic factors but little research has been
done to determine if mental health constructs impact future knee pain
or function. The goals of this study were to determine whether baseline
depression (measured with the CESD), knee related conﬁdence (measured
on a Likert scale) and general psychological distress (measured with the
SF-12) inﬂuenced the change in pain and functional status outcomes during
two years of follow up.
Methods: To deﬁne the sampling frame we included only persons who
reported baseline pain of 1 or greater on a 0 to 10 scale in at least one knee
and had no knee or hip surgery during the two-year follow-up (n=3407).
The four outcome variables of interest included performance-based mea-
sures of repeated chair standing and the 20 meter walk test, and self report
measures of pain and disability (WOMAC) where the worst score of the
two knees was used as a person-level measurement. Linear mixed effects
models were used to assess the association of each mental health variable
with the change of each outcome measure over time. Examination of the
descriptive data for the entire sample indicated that little change occurred
in the outcome measures. As importantly, change was highly dependent on
baseline outcome score. For example, persons scoring in the lowest quartile
(least pain) on WOMAC Pain at baseline increased their mean score by
0.2 WOMAC points at 1 year while persons in the highest quartile (worst
pain) had reductions in their mean 1 year scores of 6.6 WOMAC points.
Because change was highly dependent on baseline outcome, we adjusted
for the baseline score for all analyses. All variables prognostic of pain
or function identiﬁed in previously published large sample cohort studies
were considered, and covariates signiﬁcantly associated with the change
in outcome at signiﬁcance level 0.10 were included in the multivariate
analyses to determine the independent role of each of the mental health
variables on outcome.
Results: Depression was signiﬁcantly predictive of the change in WOMAC
Pain and Disability outcomes, 20 meter walk time and repeated chair stand
time. However, given the very small changes overall in the outcomes,
the magnitude of change predicted for each year was very small. For
example, for WOMAC pain, each point increase in depression at baseline
resulted in a 0.02 point increase in WOMAC Pain scores each year. This
ﬁnding was highly signiﬁcant (p=.0008) and very robust (Estimate = 0.02,
Standard error = 0.006). Knee conﬁdence was not predictive of change for
any outcome. General psychological distress as measured with the SF-12
Mental Health score was predictive of change in 20 meter walk times and
WOMAC Pain.
Conclusions: The most consistent psychological predictor of the change in
WOMAC and performance outcomes during the two-year follow up was
depression. Although depression in particular appears to be a statistically
robust predictor of outcome, given that change is very small and highly
dependent on baseline status, our results indicate that a considerable
degree of depression would be required to have a meaningful effect on
future function.
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Purpose: Biological markers have the potential to aid in the identiﬁcation
of people in the earliest stage of osteoarthritis (OA), prior to any evidence
of radiographic disease, when interventions would be most eﬃcacious.
We have recently shown that bone scintigraphy is a sensitive indicator
of symptomatic knee OA and may be a useful marker of early OA events
related to bone turnover. Urinary ALPHA CTX, a marker speciﬁc for local-
ized high bone turnover, reﬂecting bone resorption of newly formed type
I collagen by osteoclasts, has shown a strong correlation to the number
of bone metastases determined by scintigraphy in patients with breast
and prostate cancers. A similar pattern of local high bone turnover has
been observed by scintigraphy in patients with OA, thus ALPHA CTX was
investigated as a potential OA marker. Urinary CTXII, a well studied marker
which detects the C-telopeptide of type II collagen, has previously been
shown to be associated with radiographic disease and OA progression. We
hypothesize that urinary biomarkers related to degradation of types I and
II collagen, ALPHA CTX and CTXII, may be indicative of OA severity and
correlate to amount of high bone turnover determined by bone scan.
Methods: A total of 159 participants (118 women, 41 men) were included
who met ACR criteria for symptomatic OA and had the presence of Kellgren
Lawrence grade 1-4 radiographic OA in at least one knee. In addition to
KL grade, which represents global OA severity, compartmental OA severity,
based on scoring of osteophytes and joint space narrowing (range of 0-3 for
each feature), was determined using the standardized OARSI radiographic
atlas. Late phase bone scan images, indicative of bone turnover, were
obtained 2 hours after administration of 99mTc-MDP. Four views of each
knee (anterior, posterior, medial, and lateral) were obtained to precisely
localize intensity and site of uptake. Bone scan images were scored semi-
quantitatively by two readers at 16 joint sites, each of which was scored on
a scale of 0-3, where 0=normal, 1=mild, 2=moderate, and 3=intense. Urine
samples were obtained and stored at -80C until analysis. Concentrations
of urinary markers, ALPHA CTX and CTXII (Nordic Biosciences) were deter-
mined by ELISA and normalized to creatinine concentration. All data were
transformed logarithmically to obtain normality. All aspects of this study
were approved by the Institutional Review Board.
Results: Urinary ALPHA CTX did not correlate with severity of knee OA
based on the static radiographic features (OST and JSN) but did correlate
with the dynamic measure of bone turnover based on intensity of bone
scintigraphic uptake in the medial knee compartment. Concentrations of
urinary CTXII were strongly correlated with knee OA severity based on
osteophyte (medial > lateral OST, Table 1), but not degree of joint space
narrowing. Urinary CTXII also correlated with the dynamic measure of bone
turnover showing a correlation with intensity of bone scintigraphic uptake
in the knee (medial > lateral compartment but not the patellofemoral
compartment, Table 2).
Discussion: Urinary ALPHA CTX and CTXII are sensitive markers capable of
reﬂecting accelerated bone turnover in patients with knee OA. Both mark-
ers correlated with active bone turnover in the knee. In addition, uCTXII
correlated with radiographic OST scores. It has been suggested that the
main source of uCTXII is remodeling of type II collagen of mineralized tissue
including osteophytes and the mineralized interface between cartilage and
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bone. This supposition is supported by these data as concentrations of
uCTXII were highly correlated to the severity of OA as measured by osteo-
phyte formation, particularly of the medial compartment. The signiﬁcant
association of concentrations of collagenous urinary markers, ALPHA CTX
and CTXII, to knee bone turnover by bone scintigraphy suggests that these
markers may be useful non-invasive surrogates for active bone turnover in
knee osteoarthritis.
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Purpose: Osteoarthritis (OA) is the most common rheumatic pathology,
characterized mainly by cartilage degradation. Despite its high preva-
lence, the diagnosis methods currently available are limited and lacked
of sensitivity. Therefore, there is a considerable interest pointed in the
characterization of new speciﬁc OA biomarkers in biological ﬂuids. In
this work we aimed to set up a proteomic method for the large-scale
identiﬁcation and quantisation of proteins in serum from OA patients and
their comparison with healthy donors.
Methods: Serum samples were obtained from OA patients at different
stages of the disease (50 samples from grade II and 50 from grade IV),
and 50 control donors. To reduce interindividual variability, samples were
grouped in pools made from 10 patients. To reduce the dynamic range of
protein concentrations and be able to identify minority proteins, the top
twenty most abundant proteins in crude serum ﬂuids were removed by
aﬃnity chromatography using the immunodepletion column ProteoPrep®
20 (Sigma Aldrich). Proteins from each pool were quantiﬁed, digested with
trypsin and differentially labelled with isobaric tags using iTRAQ method-
ology (ABSCIEX). Then, peptides from the three conditions were mixed,
separated and analyzed by two dimensional LC coupled to MALDI-TOF/TOF
mass spectrometry. Identiﬁcation and relative quantiﬁcation of the proteins
were performed using ProteinPilot 2.0 software (ABSCIEX). Only proteins
identiﬁed with at least 95% conﬁdence were reported. PSPEP program was
used independently to calculate False Discovery Rates.
Results: The immunodepletion and subsequent proteomic analysis of the
samples led to the identiﬁcation of around 160 different proteins in the
serum pools, with at least one peptide and a conﬁdence higher than 99.9%.
Measurement of the different iTRAQ tags intensities allowed the relative
quantiﬁcation of each protein under the three conditions of the study
(control, OA grade II and OA grade IV). At this point, we have already
analyzed results from 60 samples. Data were normalized and we considered
signiﬁcant those changes with a ratio OA:N >1.2 or <0.8 and a p-value
below 0.05.
With these considerations, 29 proteins were found to be modiﬁed in the
serum of OA patients (17 increased and 12 decreased) when compared to
Table 1. Serum Proteins altered in OA patients when compared to healthy donors
Early OA (Grade II) Late OA (Grade IV) OA (Both stages)
Increased
Apolipoprotein E Complement C4-B Alpha-1B-glycoprotein
Beta-2-microglobulin Heparin cofactor 2 Alpha-2-HS-glycoprotein
Plasma protease C1 Histidine-rich glycoprotein Apolipoprotein B-100
inhibitor Thyroxine-binding globulin CD5 antigen-like
Vitamin K-dependent prot. S Complement C3
Ig lambda chain C
Ig mu chain C
Mannose-binding protein
CN-acetylmuramoyl-L-alanine
amidase
Decreased
Apolipoprotein A-IV Alpha-2-macroglobulin Apolipoprotein A-I
Complement component Complement component C7 Attractin
C8 beta chain Plasma kallikrein Fibronectin
Glutathione peroxidase Plasma protease C1 inhibitor
Serum albumin
Zinc-alpha-2-glycoprotein
healthy donors (see Table 1). From these, 12 were altered independently
of the degree of the disease, 6 were modiﬁed only in early stages (grade
II), and 11 exclusively in advanced OA (grade IV). The reported altered
proteins, which are now putative OA biomarker candidates, are involved in
a wide range of biological functions, such as immune response, inﬂamma-
tion processes, lipid metabolism, oxidative stress defence, transport or cell
adhesion.
Conclusions: A number of novel putative OA serum protein biomarkers
have been described. Validation of these results on a higher number of
samples will be necessary for the design of a ﬁnal panel, which will
undoubtedly be useful for OA diagnosis and progression studies.
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Y.A. Savitskaya, C. Duarte, R. Tellez, N. Marin, E. Morales, A. Izaquirre,
C. Ibarra
Natl. Inst. of Rehabilitation, Mexico City, Mexico
Purpose: In kOA disease progression and chronic inﬂammation is pro-
moted by combinations of principle components of angiogenesis, the
kallikrein-kinin and rennin-angiotensin systems, which play essential roles
in the maintenance of vascular immune homeostasis.The humoral immune
response represents a form of biological ampliﬁcation of signals that are
otherwise weak due to very low concentrations of self-antigen, especially
in the early stages of kOA. To investigate the speciﬁc presence of NA
(IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF) in the peripheral blood sera
of patients with kOA and healthy individuals: focusing on novel immune
disease-associated biomarkers of angiogenesis.
Methods: In order to quantify NA to EM in the sera, were designed,
synthesized and then used to develop an ELISA, in which antigens coupled
to matrix was coated on microtiters plates. Serum samples were incubated
in the plates, after which bound Ig anti-EM was detected with mouse
anti-human Ig-HRP. Levels NA-EM in a cohort of controls differed by more
than 100-fold, whereas the ﬂuctuation of EM-NA levels in individuals over
time was small (coeﬃcient of variation 8%). Following this procedure, we
examined variations in the levels of NA recognized a panel of self-antigens
in the sera from healthy individuals and kOA patients. Blood samples were
obtained from a cohort of 250 patients with symptomatic kOA (age range
45-79) fulﬁlling the American College of Rheumatology criteria for OA of
the knee joint and 250 age- and sex- matched healthy individuals. All
kOA patients had involvement of the knee joint with typical radiographic
changes graded Kellgren&Lawrence classiﬁcation. Pain was scored on a
visual analogue scale (VAS) immediately after walking 50 m. All kOA
patients are with persistent pain longer than 6 months. Parameters for
function were performed by Lequesne’s functional indexes.
Results: Different classes of NA (IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF)
were detected with our ELISA protocol in the sera of kOA patients as well
as in the sera of healthy individuals. At time of inclusion kOA patients
(100%) had signiﬁcantly higher serum BK-IgG levels relative to normal
